Quantcast

Latest Neurodegeneration Stories

Genetic Legacy Of A Rare Brain Disorder Traced Back To The Ottoman Empire
2014-04-25 05:17:10

redOrbit Staff & Wire Reports - Your Universe Online Scientists have detected a previously unknown neurodegenerative disorder stemming from a single mutation in one lone individual who lived approximately 16 generations ago during the days of the Ottoman Empire in Turkey, according to two studies appearing in Thursday’s edition of the journal Cell.  [ 1 ] [ 2 ] Two international teams of researchers, each of which was performing DNA sequencing of thousands of Turkish children...

2014-04-24 10:52:56

TAU discovers that protein clusters implicated in neurodegenerative diseases actually serve to protect brain cells People diagnosed with Huntington's disease, most in their mid-thirties and forties, face a devastating prognosis: complete mental, physical, and behavioral decline within two decades. "Mutant" protein clusters, long blamed for the progression of the genetic disease, have been the primary focus of therapies in development by pharmaceutical companies. But according to new...

2014-04-22 12:09:23

Research published in the Journal of Molecular Biology Researchers from NeuroPhage Pharmaceuticals, Inc. have engineered a series of molecules with the potential to treat most neurodegenerative diseases that are characterized by misfolded proteins, such as Alzheimer's, Parkinson's and Huntington's diseases. These molecules are based on what the Company calls a general amyloid interaction motif, or GAIM, which recognizes a characteristic common to many toxic, misfolded proteins, not just...

2014-04-22 08:30:14

--Research Published in the Journal of Molecular Biology-- CAMBRIDGE, Mass., April 22, 2014 /PRNewswire/ -- Researchers from NeuroPhage Pharmaceuticals, Inc. have engineered a series of molecules with the potential to treat most neurodegenerative diseases that are characterized by misfolded proteins, such as Alzheimer's, Parkinson's and Huntington's diseases. These molecules are based on what the Company calls a general amyloid interaction motif, or GAIM, which recognizes a...

2014-04-15 12:30:22

Scientist's 'monumental' discoveries underlie one of the largest fields in modern biomedical research, including efforts to treat cancer and neurodegenerative diseases ALBANY, N.Y., April 15, 2014 /PRNewswire-USNewswire/ ----Alexander Varshavsky, Ph.D., whose landmark discoveries transformed the understanding of how cell behavior impacts diseases including cancer, autoimmune disorders and other illnesses, has been selected to receive the prestigious Albany Medical Center Prize in...

2014-04-14 14:20:45

Alzheimer's disease, the primary cause of dementia in the elderly, imposes a tremendous social and economic burden on modern society. In Japan, the burden of the disease in 2050 is estimated to be a half a trillion US dollars, a figure equivalent to the government's annual revenues. Unfortunately, it has proven very difficult to develop drugs capable of ameliorating the disease. After a tremendous burst of progress in the 1990s, the pace of discoveries has slowed. Dr. Saido believes that...

2014-03-26 12:28:27

Biomedical research institute appoints two key positions, expanding its impact on neurodegenerative science GRAND RAPIDS, Mich., March 26, 2014 /PRNewswire/ -- Van Andel Research Institute's Center for Neurodegenerative Science continues to expand its research portfolio and increase its impact in the field of Parkinson's disease research. The Center recently appointed Dr. Jiyan Ma, whose laboratory studies prions, the misfolded proteins associated with many contagious...

2014-03-25 08:31:05

--Funds Will Advance Novel Approach for Treatment of Alzheimer's Disease and Other Diseases of Protein Aggregation-- CAMBRIDGE, Mass., March 25, 2014 /PRNewswire/ -- NeuroPhage Pharmaceuticals, Inc. today announced the completion of a $17 million Series D financing from existing and new investors to advance the Company's lead candidate, NPT088, and potential next-generation compounds toward clinical trials. NPT088 has the potential to treat a wide range of neurodegenerative diseases,...

2014-03-18 23:29:58

The MSA Coalition announced in January 2014 the funding of five MSA research grants for a total of $219,000 including the project "Peripheral delivery of brain-targeted neurosin as a novel treatment for MSA". This pre-clinical proof-of-concept study in mice is being led by Eliezer Masliah, M.D. (University of California San Diego). San Diego, CA (PRWEB) March 18, 2014 The Multiple System Atrophy Coalition has awarded a $50,000 grant to Dr. Eliezer Masliah of the University of...

2014-03-14 23:24:40

The MSA Coalition announced in January 2014 the funding of five MSA research grants for a total of $219,000 including the project "Stem cell-based Therapeutics Platform for MSA." The project is being led by Vikram Khurana, M.D, Ph.D. (Massachusetts General Hospital) and could lead to genomics and small molecule discovery platform for multiple system atrophy (MSA). Boston, Massachusetts (PRWEB) March 14, 2014 The Multiple System Atrophy Coalition has awarded a $50,000 grant to...


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related